HUMAN CLINICAL TRIAL FOR SAFETY OF PM-208 ANTI-SHOCK DRUG
$1,799,970
| Recipient | PERFUSION MEDICAL, INC. UEI XEDJGXP1K889 |
|---|---|
| Award ID | FA864924P0531 |
| Award amount | $1,799,970 |
| Award type | PURCHASE ORDER |
| Awarding agency | Department of Defense — Department of the Air Force |
| NAICS | 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) |
| PSC | AC32 |
| Set-aside | Small business |
| Start date | Jun 24, 2024 |
| End date | May 18, 2026 |
| Place of performance | HERNDON, VA |
| Record updated | Sep 6, 2024 |
View the official award record
More awards won by PERFUSION MEDICAL, INC.
DHA SBIR DIRECT TO PHASE II MEDICAL R&D CONTRACT FROM PROPOSAL NO. H2D-0122 FOR "IND-ENABLING STUDIES OF PM-208: A NOVEL PRE-HOSPITAL ANTI-SHOCK THERAPEUTIC"
Department of Defense · $2,986,773 · Sep 15, 2023
RESEARCH AND DEVELOPMENT OF OPTIMAL DOSING AND FORMULATION OF PM-208 (PEG-20K/8K) FOR AF FIELD USE
Department of Defense · $1,799,322 · Feb 9, 2024
IND-ENABLING STUDIES OF PM-208: A NOVEL PRE-HOSPITAL ANTI-SHOCK THERAPEUTIC
Department of Defense · $1,499,773 · Apr 10, 2026
Our catalog shows awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. $0 today for 14 days (card required), then $49.99/month.
Search open bids